(S)-Bexicaserin
(S)-Bexicaserin ((S)-LP352) is the less active S-enantiomer of Bexicaserin (HY-15601). Bexicaserin is a 5-HT2C agonist with the potential to be used in the study of obesity and psychiatric-related diseases.
For research use only. We do not sell to patients.
- CAS No.: 2035818-21-2
- Formula: C15H19F2N3O
- Molecular Weight:295.33
-
Storage:
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
All 5-HT Receptor Isoforms
More
Biological Activity
Description
IC50 & Target
|
5-HT2C Receptor |
5-HT 2C |
In Vitro
(S)-Bexicaserin (compound 2) can be used for weight management, inducing satiety, and reducing food intake, as well as for research into type 2 diabetes, Dravet syndrome, drug addiction, alcohol addiction, and epileptic seizures[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 2035818-21-2
-
Appearance Solid
-
Molecular Weight 295.33
-
Formula C15H19F2N3O
-
Color White to off-white
-
SMILES
FC(F)CNC(C1=C2C3=C(C=C1)CNCCN3C[C@H]2C)=O
-
Synonyms
(S)-LP352
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Protocols
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
Purity & Documentation
-
Data Sheet (279 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)